Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerstein

Showing results (51-60 of 1,912) with videos related to

Pageof 192
Sort By:
Journal of Cardiothoracic and Vascular Anesthesia|September 30, 2011
A word of caution regarding transesophageal echocardiography and penetrating chest traumaNeal Stuart Gerstein
Diabetes Care|January 1, 1994
Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literatureH C Gerstein
Lancet (London, England)|February 24, 2020
Dulaglutide slows kidney disease in type 2 diabetes - Author's replyHertzel C Gerstein
Diabetes Research and Clinical Practice|January 8, 2017
High altitude is not a risk factor for type 2 diabetes mellitusWalter Calderón-Gerstein
Nature Reviews. Endocrinology|July 29, 2015
Diabetes: Dysglycaemia as a cause of cardiovascular outcomesHertzel C Gerstein
Circulation|May 31, 2022
Shouldn't Preventing Type 2 Diabetes Also Prevent Its Long-Term Consequences?Hertzel C Gerstein
International Journal of Clinical Practice. Supplement|November 22, 2001
Diabetes and the HOPE study: implications for macrovascular and microvascular diseaseH C Gerstein
Diabetes/Metabolism Research and Reviews|September 27, 2002
Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPEHertzel C Gerstein
The American Journal of Drug and Alcohol Abuse|January 1, 1976
The structure of heroin communities (in relation to methadone maintenance)D R Gerstein
Evidence-Based Cardiovascular Medicine|December 29, 2005
Ramipril slowed the decline in renal function among patients with nephropathy and proteinuria not due to insulin-dependent diabetes mellitusH C Gerstein
Pageof 192

Showing results (51-60 of 1,912) with videos related to

Sort By:
Pageof 192
Journal of Cardiothoracic and Vascular Anesthesia|September 30, 2011
A word of caution regarding transesophageal echocardiography and penetrating chest traumaNeal Stuart Gerstein
Diabetes Care|January 1, 1994
Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literatureH C Gerstein
Lancet (London, England)|February 24, 2020
Dulaglutide slows kidney disease in type 2 diabetes - Author's replyHertzel C Gerstein
Diabetes Research and Clinical Practice|January 8, 2017
High altitude is not a risk factor for type 2 diabetes mellitusWalter Calderón-Gerstein
Nature Reviews. Endocrinology|July 29, 2015
Diabetes: Dysglycaemia as a cause of cardiovascular outcomesHertzel C Gerstein
Circulation|May 31, 2022
Shouldn't Preventing Type 2 Diabetes Also Prevent Its Long-Term Consequences?Hertzel C Gerstein
International Journal of Clinical Practice. Supplement|November 22, 2001
Diabetes and the HOPE study: implications for macrovascular and microvascular diseaseH C Gerstein
Diabetes/Metabolism Research and Reviews|September 27, 2002
Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPEHertzel C Gerstein
The American Journal of Drug and Alcohol Abuse|January 1, 1976
The structure of heroin communities (in relation to methadone maintenance)D R Gerstein
Evidence-Based Cardiovascular Medicine|December 29, 2005
Ramipril slowed the decline in renal function among patients with nephropathy and proteinuria not due to insulin-dependent diabetes mellitusH C Gerstein
Pageof 192